Leveraging Genomic Sequence-to-Function Language Models for the Design of Antisense Oligonucleotides

Wednesday, January 27, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
AI in Drug Discovery Stage
Day 1 - Wednesday 27th January
AIAI in Drug DiscoveryDrug Discovery

Information

This session will explore:

  • An introduction to Genomic sequence-to-function language models
  • Why genomic sequence-to-function models are promising for ASO design
  • Preliminary results: reproducing the effect of Nusinersen on the SMN2 gene using 
  • the Borzoi model 
  • Limitations and perspectives